Daraxonrasib improved symptoms enough that some patients could resume ​activities they had previously abandoned and a new benchmark for treating the deadly cancer.
Tag: Regulatory Oversight
The U.S. FDA’s new, looser regulation of new vapes and nicotine pouches will potentially unleash hundreds more such products on the market in the coming weeks and months, ​according to three current and former Trump administration officials.